UN Head Says 17 Drug Makers Promise More AIDS Research For Poor
This article was originally published in PharmAsia News
The head of the United Nations says major drug and diagnostics makers have promised to increase their research into AIDS drugs and diagnostics that are more affordable in poorer nations. Secretary-General Ban Ki-Moon said the companies also have agreed to invest more in developing vaccines, prophylactic treatments and prevention programs. Ban said he negotiated the agreement with 17 companies, including the major multinational firms. He said current efforts are not keeping up with an epidemic that continues to grow faster than it can be treated. (Click here for more
You may also be interested in...
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.
Just as the MDR and IVDR are being implemented, increasing regulatory divergence in Europe is a growing danger to patient safety throughout the EU, not least through increasing costs and impacting device availability.
It’s time to focus on how the diagnostics sector will comply with the EU’s IVD Regulation. TÜV SÜD expert, Andreas Stange, explains why the IVD industry could be in trouble and what must be done now.